American Society of Hirudotherapy

Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis.

Comparative study published in Biochemistry (1992)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studySalivary PharmacologyDrug DevelopmentGenomics & ProteomicsSteiner V et al. · Biochemistry, 1992

Abstract

Hirudin from the leech Hirudo medicinalis is a most powerful anticoagulant, and many isoforms have been described. In the present work, the primary structure of two hirudins from the leech Hirudinaria manillensis has been elucidated. The antithrombotic activity is similar to that of H. medicinalis hirudins although the sequence identity is below 60%. Surprisingly, the hirudins were found to be glycosylated at one site. Sugar analysis after methanolysis yielded fucose, galactose, and N-acetylgalactosamine. These results combined with data from matrix-assisted laser desorption ionization mass spectrometry, plasma desorption mass spectrometry, capillary zone electrophoresis, and lectin-binding tests indicate that the sequence is Fuc-Gal beta 1-3GalNAc-(O-threonine). This structure shows an interesting similarity to human blood group H determinants.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAmino Acid SequenceAmino AcidsAnimalsCarbohydrate ConformationGlycosylationHirudinsLeechesMolecular Sequence DataSequence AlignmentSequence Homology, Nucleic AcidStructure-Activity RelationshipThrombin

Summary

Hirudin from the leech Hirudo medicinalis is a most powerful anticoagulant, and many isoforms have been described. In the present work, the primary structure of two hirudins from the leech Hirudinaria manillensis has been elucidated.

Why This Matters for Hirudotherapy

This study elucidated the primary structure of two hirudins from the leech Hirudinaria manillensis, reporting antithrombotic activity similar to Hirudo medicinalis hirudins despite less than 60% sequence identity, and identifying a novel O-glycosylation site (Fuc-Galβ1-3GalNAc-O-threonine) with structural similarity to human blood group H determinants. For ASH and hirudotherapy, the work is directly relevant because it characterizes new leech-derived anticoagulant molecules, expanding knowledge of the molecular diversity present within the leech secretome across different medicinal leech species. The unexpected glycosylation is scientifically notable because such modifications can influence stability, pharmacokinetics, or immunogenicity of anticoagulants. An honest caveat is that this is a biochemical and structural characterization reporting antithrombotic activity; it does not establish clinical efficacy, in vivo performance, or the specific target/mechanism of these hirudins.

Citation

Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis.

Steiner V et al. · Biochemistry, 1992

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.